Clinical Trial Update: Doxil Topotecan Doublet Cancer Study [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a Doxil (liposomal doxorubicin) and topotecan doublet across multiple cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Head and Neck Cancer
• Pancreatic Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Topotecan (topotecan)

Snippet

Sponsor: Christiana Care Health Services | Conditions: Small Cell Lung Cancer, Pancreatic Cancer | Phase 1 | Status: COMPLETED